Page last updated: 2024-08-23

raloxifene hydrochloride and endothelin-1

raloxifene hydrochloride has been researched along with endothelin-1 in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altavilla, D; Arcoraci, V; Cancellieri, F; Corrado, F; Cucinotta, D; D'Anna, R; Frisina, N; Gaudio, A; Lasco, A; Morabito, N; Saitta, A; Squadrito, F; Squadrito, G	1
Chondros, C; Christodoulakos, G; Creatsas, G; Dendrinos, S; Kouskouni, E; Panoulis, C	1
Celermajer, DS; Griffiths, KA; Harmer, JA; Sader, MA; Skilton, MR	1
Cerquetani, E; Fini, M; Mercuro, G; Rosano, GM; Vitale, C; Zoncu, S	1
Au, AL; Huang, Y; Kwan, YW; Leung, FP; Leung, HS; Seto, SW; Yao, X; Yung, LM	1
Hasegawa, Y; Inaji, H; Matsumura, Y; Nakagawa, E; Nishida, M; Ohkita, M; Tanida, I	1

Trials

4 trial(s) available for raloxifene hydrochloride and endothelin-1

Article	Year
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:9 Topics: Aged; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Estrogen Replacement Therapy; Female; Hemodynamics; Humans; Middle Aged; Nitric Oxide; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vasodilation	2001
Effects of estrogen-progestin and raloxifene therapy on nitric oxide, prostacyclin and endothelin-1 synthesis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:1 Topics: Cardiovascular Diseases; Double-Blind Method; Endothelin-1; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Nitric Oxide; Norethindrone; Norethindrone Acetate; Placebos; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2002
Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease. Journal of the American College of Cardiology, 2003, Aug-20, Volume: 42, Issue:4 Topics: Aged; Biomarkers; Coronary Artery Disease; Coronary Vessels; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Female; Fibrinogen; Humans; Lipoproteins; Middle Aged; Postmenopause; Prospective Studies; Prostaglandins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vasodilation	2003
Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:6 Topics: Aged; Brachial Artery; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Endothelin-1; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Nitrates; Nitrites; Postmenopause; Pulsatile Flow; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome; Vasodilation	2004

Other Studies

2 other study(ies) available for raloxifene hydrochloride and endothelin-1

Article	Year
Endothelium-independent relaxation to raloxifene in porcine coronary artery. European journal of pharmacology, 2007, Jan-26, Volume: 555, Issue:2-3 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium Channel Blockers; Calcium Channels; Calcium Chloride; Coronary Vessels; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; In Vitro Techniques; Peptides; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Serotonin; Swine; Tetraethylammonium; Vasoconstrictor Agents; Vasodilation	2007
Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats. European journal of pharmacology, 2009, Jul-01, Volume: 614, Issue:1-3 Topics: Animals; Blood Pressure; Body Weight; Endothelin-1; Female; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Monocrotaline; Organ Size; Ovariectomy; Pulmonary Artery; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Substrate Specificity; Time Factors; Ventricular Dysfunction, Right	2009

Article

Year

Endothelium-independent relaxation to raloxifene in porcine coronary artery.

European journal of pharmacology, 2007, Jan-26, Volume: 555, Issue:2-3

Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium Channel Blockers; Calcium Channels; Calcium Chloride; Coronary Vessels; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; In Vitro Techniques; Peptides; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Serotonin; Swine; Tetraethylammonium; Vasoconstrictor Agents; Vasodilation

2007

Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.

European journal of pharmacology, 2009, Jul-01, Volume: 614, Issue:1-3

Topics: Animals; Blood Pressure; Body Weight; Endothelin-1; Female; Heart Ventricles; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung; Monocrotaline; Organ Size; Ovariectomy; Pulmonary Artery; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Substrate Specificity; Time Factors; Ventricular Dysfunction, Right

2009